PunjiPUNJI
Live AI ↗
Pharmaceuticals & BiotechnologyMid Cap

Aurobindo Pharma Ltd.

AUROPHARMA · ISIN: INE406A01037

Constituent of NIFTY 100 TRI (0.20%), NIFTY 50 (0.42%), NIFTY 500 TRI (0.22%), NIFTY LMC 250 TRI (0.52%), NIFTY MC 150 TRI (1.05%)

Close (as of 2026-09-08)
₹1692
+1.93% today
Day Range
₹1655 - ₹1698.8
Quality Score (as of 2026-06-30)
72.7/100

Earnings (TTM)

CHART

Aurobindo Pharma Ltd. - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr978188 Cr1956376 Cr2934564 Cr3912752 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

16.63%

EBITDA Margin (TTM)

64

EPS (TTM)

3.32%

EPS Growth (5Y)

6.32%

EPS Growth (10Y)

Technicals

60.75

RSI (14)

1602.74

SMA (50)

1376.09

SMA (200)

25.89

ADX (14)

1717

52-Week High

1021

52-Week Low

65.53%

1Y Return

138.8368

Avg Traded Value (20D, ₹Cr)

As of 2026-09-08.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

51.88%48.12%TOP 2100%
Promoter 51.88%Public 48.12%

F&O Sentiment

Nearest expiry: 2026-09-29 · As of 2026-09-07.

0.4802

PCR (OI)

0.6032

PCR (Volume)

1640

Max Pain Strike

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Stock data · Not financial advice · Past performance does not indicate future returns